Loading…
← CockpitCompetitor Analysis › 600587.SS Shinva Medical Instrument Co. Ltd. Class AOpen in the cockpit ↗

Shinva Medical Instrument Co. Ltd. Class A600587.SSCompetitor analysis, valuation and peers

China · CNY·Health Care›Medical Distributors

Chinese medical-equipment maker producing hospital sterilization, disinfection and clinical laboratory instruments.

≈ A Chinese STERIS Corporation (sterilization equipment)Momentum strong 79
Mkt cap
$1.10B
US dollars, full cap
Free float
61%
of shares outstanding
$/day
$15.6M
20-day average traded
Fwd P/E
13.4×
forward earnings
ROIC−WACC
+1.6 pp
WACC 6.2%
Hurdle
-8 pp
Req g minus delivered
Next earnings
156 days
23 Apr 2027
Close · CNYCN¥12.09
1D-1.5%
1W-3.9%
1M-4.8%
3M-6.2%
6M-10.4%
YTD-16.0%
1Y-20.9%
ATR %2.4%
52w lowhigh30.0% off high

What Shinva Medical Instrument does

Chinese medical-equipment maker producing hospital sterilization, disinfection and clinical laboratory instruments.

Sells sterilisers and lab instruments to hospitals mainly through public tenders, so orders follow hospital budgets and equipment-upgrade programmes. Once equipment is installed, spare parts and service bring repeat income, and drug makers buy its packaging and sterilisation lines.

In one line: A Chinese STERIS Corporation (sterilization equipment).

Products and services

  • Sterilization/disinfection equipment
  • Clinical laboratory instruments
  • Pharmaceutical packaging equipment

Customers

  • Hospitals
  • Pharmaceutical manufacturers

Where it sits in the supply chain

  • Health Care
  • Medical equipment
  • Hospital sterilization & disinfection…

What could go right

  • Hospital equipment upgrade demand

What could go wrong

  • Hospital capex/procurement budget cycles

Moat: narrow (installed base, regulatory licence). Long hospital installed base and medical-device registration approvals favor an incumbent.

Headquarters: Zibo, Shandong, China · Employees: 7,982

Named competitors

  • STERIS STE
  • Getinge GETI-B.ST
  • Shinva peer Lifotronic (private) private or unlisted

Shinva Medical Instrument at a glance

Size Shinva Medical Instrument (600587.SS) is a China Health Care company (Medical Distributors) with a market value of $1.10B, the 1979th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥12.09 on 18 Nov 2026.

Performance Over six months the shares fell 10.4%, against -2.3% for the median peer and -20.0% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.

Growth Revenue grew 5.8% over the last twelve months (peer median +5.0%); the operating margin is 5.2% (peer median 2.3%).

Valuation It trades at 13.4× forward earnings against a peer median of 15.8× (4th cheapest of 12).

Price implies For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +1%, so the hurdle is -8 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.6 points above its cost of capital (6.2% WACC).

Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).

Relative performance

909510021 May 202621 Aug 202618 Nov 2026Peer median 99600587.SS 91
Six months, rebased to 100: Shinva Medical Instrument against the median of its 20 peers (local-currency closes).

Shinva Medical Instrument financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥10.1BCN¥9.70BCN¥9.95BCN¥9.93BCN¥9.24B
Revenue growth—-3%0%+7%—
Gross profitCN¥2.65BCN¥2.33BCN¥2.47BCN¥2.50BCN¥2.35B
EBITDAn/aCN¥807MCN¥950MCN¥917MCN¥812M
Net incomeCN¥453MCN¥526MCN¥692MCN¥654MCN¥500M
Free cash flowCN¥647MCN¥408MCN¥88.5MCN¥511MCN¥146M
Capital expenditureCN¥150MCN¥382MCN¥421MCN¥536MCN¥248M
Total debtCN¥1.49BCN¥1.56BCN¥1.59BCN¥1.54BCN¥1.90B

Quarterly statements and history in the cockpit →

Shinva Medical Instrument competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%0%+20%7476DOCM301584600713603368ARJO-BENTERO68263360RDCNEU81296006283013709987008930605136ASKER600587.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Shinva Medical Instrument is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%+30%20×40×7476603368ARJO-BENTERO68263360NEU81292733ASKER600587.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shinva Medical Instrument is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%-20%0%20%7476301584603368ARJO-BENTERO68263360NEU600628301370008930605136ASKER600587.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shinva Medical Instrument is the large dot.

Shinva Medical Instrument competitors and peer comparison

Head to head with its named competitors (600587.SS vs STE vs GETI-B.ST)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Shinva Medical Instrument 600587.SS$1.10B-10%+6%5%13.4×-6.9%
Steris STE$25.2B+21%+8%20%21.9×14.0%
Getinge GETI-B.ST$7.45B+40%-4%14%21.1×5.0%

How Shinva Medical Instrument compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shinva Medical Instrument against its 20 peers (data as of 18 Nov 2026)
Measure600587.SSPeer medianRank in peer set
1-month return-4.8%-0.1%5th lowest of 21
6-month return-10.4%-2.3%7th lowest of 21
Distance from 52-week high-30.0%-18.5%7th lowest of 21
Revenue growth (TTM)+5.8%+5.0%10th highest of 21
Operating margin5.2%2.3%5th highest of 21
Forward P/E13.4×15.8×4th cheapest of 12
Growth the price implies (Req g, 7 yrs)-6.9%-0.5%4th least demanding of 17
Growth delivered (Del g)+1.2%+6.9%3rd lowest of 17
Hurdle (Req g minus delivered)-8.1 pp-5.8 pp7th least demanding of 17
ROIC minus cost of capital+1.6 pp+0.3 pp8th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shinva Medical Instrument 600587.SSChina$1.10B-10%+6%5%13.4×-6.9%+1.2%
AS ONE 7476.TJapan$1.10B+25%+10%12%18.4×0.0%+6.3%
DocMorris DOCM.SWSwitzerland$1.08B+169%+11%-8%n/an/an/a
Shanghai C and D INNOSTIC Medical Technology 301584.SZChina$1.06B-33%+8%3%n/a-2.7%+17.9%
Nanjing Pharmaceutical 600713.SSChina$999M-2%+3%2%n/an/an/a
Guangxi LiuYao 603368.SSChina$975M+1%+2%5%9.5×-9.7%+6.0%
Arjo ARJO-B.STSweden$974M+42%0%8%21.1×-1.0%+3.9%
Entero Healthcare Solutions ENTERO.NSIndia$925M+60%+35%4%47.7×24.7%+29.9%
Shanghai Haohai Biological Technology 6826.HKHong Kong$897M-24%-5%-2%7.7×17.0%+12.4%
Ship Healthcare 3360.TJapan$1.38B+19%+6%3%14.6×-14.5%+7.6%
Redcare Pharmacy RDC.DEGermany$1.50B+53%+19%0%n/an/an/a
Neuca NEU.WAPoland$795M-9%+8%2%15.3×5.3%+8.1%
Toho 8129.TJapan$1.64B-5%+4%1%22.2×-4.6%+5.1%
Arata 2733.TJapan$576M-3%+3%1%12.0×-6.2%+3.8%
Shanghai New World 600628.SSChina$573M-10%-2%6%n/a-1.6%+1.0%
GKHT Medical Technology 301370.SZChina$525M-24%-11%1%n/a13.1%+7.5%
Suzuken 9987.TJapan$2.36B+8%+5%1%15.8×-10.4%+3.2%
Hanmi Science 008930.KSSouth Korea$2.58B+48%+6%4%n/a26.0%+9.6%
Shanghai Lily & Beauty Cosmetics 605136.SSChina$449M-28%+5%2%n/a21.1%-18.1%
Asker Healthcare ASKER.STSweden$2.69B-14%+12%7%24.8×4.7%+12.7%
Thalys Medical Technology 603716.SSChina$446M-33%-43%-18%n/an/an/a

Questions

Who are Shinva Medical Instrument's main competitors?
Named competitors: STERIS (STE), Getinge (GETI-B.ST), Shinva peer Lifotronic (private) (private or unlisted). The cockpit's measured peer set (industry) also includes AS ONE (7476.T), DocMorris (DOCM.SW), Shanghai C and D INNOSTIC Medical Technology (301584.SZ), Nanjing Pharmaceutical (600713.SS), Guangxi LiuYao (603368.SS), Arjo (ARJO-B.ST).
Is Shinva Medical Instrument expensive compared with its peers?
On forward p/e it trades at 13.4× against a peer median of 15.8×, 4th cheapest of 12 in its peer set. For today's price to make sense, revenue must grow about -7% a year for seven years (Req g). Recent delivered growth is +1%, so the hurdle is -8 pp: the price already allows for a slowdown.
How has Shinva Medical Instrument stock performed?
Over six months to 18 Nov 2026 the shares returned -10.4% against -2.3% for the median peer; over one year -20.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.